Business Context and Reporting Period
This Form 8-K filing by Intrexon Corporation (not Precigen, Inc.) covers events occurring on March 26, 2014, with the report dated March 27, 2014. The filing details the formation of a joint venture, Intrexon Energy Partners, LLC ("IEP"), and the execution of a worldwide Exclusive Channel Collaboration Agreement ("ECC") to commercialize synthetic biology technology for converting natural gas into liquid fuels and lubricants.
Key Financial Metrics and Transaction Details
- Upfront Technology Fee: IEP agreed to pay Intrexon $25.0 million as an upfront technology access fee.
- Capital Contributions: Intrexon contributed $25.0 million worth of technology for a 50% membership interest in IEP. Investors contributed $25.0 million in cash for the remaining 50% interest.
- Private Placement Proceeds: Intrexon sold 972,004 shares of common stock to the Investors at $25.72 per share, generating gross proceeds of $25.0 million.
- Future Capital Commitments: Both Intrexon and the Investors have committed to make additional capital contributions of up to $25.0 million each, subject to Board request.
- Agreement Term: The ECC has a term of twenty years.
Material Changes and Agreements
The primary material change is the entry into the ECC and the LLC Agreement. Under the ECC, IEP receives an exclusive worldwide license to use Intrexon's proprietary technology for the design and production of genetically modified cells to create motor gasoline, aviation turbine fuel, diesel fuel, and lubricant base oils. IEP is responsible for all development, manufacturing, and commercialization costs. The agreement includes governance committees and specific termination rights, including a 90-day notice period for IEP and termination rights for Intrexon regarding breach or failure to diligently pursue "Superior Products."
Outlook, Risks, and Contingencies
- Management Structure: IEP is governed by a five-member Board of Managers, with two members designated by Intrexon and three by the Investors.
- Related Party Transaction: One of the Investors is an affiliate of Randal J. Kirk, the Chairman and CEO of Intrexon, who purchased 243,001 shares ($6.25 million) in the private placement.
- Termination Risks: The ECC can be terminated by either party for uncured breaches. Intrexon retains the right to terminate if IEP fails to diligently pursue specific products or attempts to assign the agreement improperly.
- Change of Control: Intrexon holds a call right to purchase all Investor interests in IEP in the event of a change of control regarding Intrexon.
Investor Verification Checklist
- Verify the specific terms of the "Superior Product" definition in the ECC, as failure to pursue these products allows Intrexon to terminate the agreement.
- Confirm the status of the $25.0 million upfront technology fee and whether it has been recognized as revenue or deferred.
- Review the full text of the LLC Agreement to understand the voting rights and exit strategies (tag-along/drag-along rights) for the 50% Investor stake.
- Assess the financial impact of the $25.0 million private placement on Intrexon's cash position and dilution to existing shareholders.
- Examine the related party transaction disclosures regarding the affiliate of the CEO to ensure compliance with conflict of interest policies.